Numbers

The Numbers

Garware Hi-Tech Films is a capital-light, debt-free specialty films compounder hiding inside what the market still sometimes prices as a cyclical BOPET converter. Over five years, revenue has nearly doubled (₹925 Cr → ₹2,109 Cr) while net profit has quadrupled (₹86 Cr → ₹331 Cr) — the entire thesis is margin, not tonnage. FY25 operating margin of 21% is the structural print the bulls pay for; the Q3 FY26 dip to 15% is the single number that most threatens the re-rating.

Snapshot

What the business looks like — 12-year shape

Revenue drifted sideways in the ₹830–950 Cr band from FY14 through FY20 — a classic commodity BOPET profile. The step-change starts FY21 and compounds through FY25 as specialty mix (sun-control, paint-protection film, IP labels) takes over.

The margin chart is the actual thesis. Operating margin doubled from 8% (FY14–17) to 17% (FY20) and then to 21% (FY25) — the inflection tracks the specialty-mix transition, not a cycle peak.

Quarterly trajectory — is the 21% margin holding?

The last 13 quarters show the mix shift clearly, but also flag that the peak print is not yet a stable baseline.

Earnings power — EPS has quadrupled since FY20

5-year EPS CAGR is 31% (FY20 to FY25); 10-year is 34%. Share count has held at ~23.2M across the whole period — there is no dilution offset.

Cash generation — are the earnings real?

Cash conversion is strong: operating cash flow exceeds or closely tracks net income in 11 of the last 12 years. FCF swings because capex is lumpy (Aurangabad plus Nasik expansion, PPF line, TPU extrusion), but the underlying CFO/NI ratio averages roughly 1.5x over the period.

FY25 is a clean test: ₹330 Cr CFO against ₹331 Cr net profit (1.00x conversion) and ₹275 Cr capex consuming most of it. The announced ₹125 Cr PPF line (FY26) and ₹118 Cr TPU extrusion (FY27) will keep FCF suppressed for two more years — the reinvestment story dominates the near-term yield story.

Returns on capital — the real re-rating driver

ROCE has more than doubled from 10% (FY20) to 21% (FY25). This is the single series that justifies a 30x multiple on a company that sells plastic film.

Balance sheet — debt has gone to zero

Total borrowings: ₹440 Cr (FY14) to ₹141 Cr (FY23) to zero (FY24 and FY25). Equity has grown 4.3x over the same period from internal accruals. Net cash (investments plus liquid assets) is now around ₹643 Cr.

The capex cycle runs off internal cash flow. Zero debt is not a liquidity cushion narrative — it is an optionality statement. Management can fund both announced lines (₹243 Cr combined) and still keep net cash positive.

Working capital — inventory is the one thing to monitor

Debtor days have compressed from 25 to 7 — the customer mix has become higher-quality (automotive OEMs, architectural distributors) rather than generic BOPET buyers. Inventory days sitting at 110–145 is the structural feature of specialty film making (slow-moving SKUs, colour and gauge variants) and should not be mistaken for stockpile buildup.

Peer comparison — Garware is the quality outlier

Seven Indian polyester/polymer-film names, FY25 fundamentals:

On ROCE, ROE, and balance-sheet quality Garware sits at the top of this list. It is materially smaller than SRF or Uflex but earns more on each rupee of capital and carries none of the interest burden that has crushed Jindal Poly and Ester. P/E of 30x looks expensive versus Cosmo First (12x) or Uflex (12x), but those companies are running 10–11% margins and single-digit ROCE. The right comparator on operating quality is SRF at 40x — on that basis Garware trades at a discount.

Valuation — what's priced in

The stock has traded a ₹2,681–4,800 band across the year. The June 2025 peak coincided with the Q1 FY26 print; the late-August and January lows tracked the Q3 FY26 margin concern. Current ₹4,005 is roughly mid-range.

Ownership — FII interest has gone from zero to 4%

Promoter holding is rock-steady at 60.73% (no selling, no pledging). The move that matters is FII holding from 0.10% (Mar 2022) to 3.96% (Dec 2025) — institutional discovery is under way, which helps explain multiple expansion but also means the stock is now sensitive to quarterly-print volatility.

Fair-value scaffolding

The bear case requires OPM to normalise to 15–16% (roughly the Q3 FY26 print extended forward); the bull case requires the PPF line to show through cleanly in FY27 at current specialty margins. The base case is essentially "current multiple, current earnings trajectory" — there is no obvious mispricing from here unless you have a view on which way margins resolve.

Bottom line

The numbers confirm a real, durable margin re-rating — OPM 8% to 21% over a decade, ROCE 5% to 21% in the same period, zero debt, and EPS compounding at 31% for five years with no dilution. The numbers contradict the common description of Garware as a cyclical BOPET converter; the returns profile and balance-sheet discipline read more like a specialty chemical compounder. What to watch through FY27: the Q4 FY26 and Q1 FY27 operating-margin prints, and the ramp rate on the ₹125 Cr PPF line — those two data points together decide whether 21% is the new normal or just a favourable cycle peak.